Skip to Main Content

Author Details

Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
2006
70
19
PMIDPaper TitleJournal TitlePublished Year
36596856CD8α+⿿dendritic cells potentiate antitumor and immune activities against murine ovarian cancers.Sci Rep2023
37541685Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.Int J Gynecol Cancer2023
37976756Immune checkpoint inhibitors with chemotherapy for primary advanced mismatch repair-deficient endometrial cancer: A cost-effectiveness analysis.Gynecol Oncol2023
37189263Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study.Cancer Res Treat2023
33246662Continued medical treatment for persistent early endometrial cancer in young women.Gynecol Oncol2021
33567699New Surgical Technique for Robotic Myomectomy: Continuous Locking Suture on Myoma (LSOM) Technique.J Clin Med2021
33871703Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer.Arch Gynecol Obstet2021
34502561Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian Cancer.Int J Mol Sci2021
34501409Single-Incision versus Multiport Robotic Myomectomy: A Propensity Score Matched Analysis of Surgical Outcomes and Surgical Tips.J Clin Med2021
34708596Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines.J Gynecol Oncol2021
34575308Effects of Perioperative Inflammatory Response in Cervical Cancer: Laparoscopic versus Open Surgery.J Clin Med2021
32161019GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of <i>BRCA1</i> and <i>BRCA2</i>.Ann Clin Lab Sci2020
31907386Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.J Hum Genet2020
32084588Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.J Minim Invasive Gynecol2020
33251780Robot-Assisted Laparoscopic Myomectomy versus Abdominal Myomectomy for Large Myomas Sized over 10 cm or Weighing 250 g.Yonsei Med J2020
32812259Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.J Clin Lab Anal2020
32110662Isolated vaginal metastasis from stage I colon cancer: A case report.World J Clin Cases2020
30599280Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.Papillomavirus Res2019
31777741Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women.Obstet Gynecol Sci2019
31590408An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy.Int J Mol Sci2019
30740961Asian Society of Gynecologic Oncology International Workshop 2018.J Gynecol Oncol2019
30740959Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline.J Gynecol Oncol2019
30887755Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma.J Gynecol Oncol2019
29780774Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer.Obstet Gynecol Sci2018
30018911Erratum: Correction of Acknowledgements.Obstet Gynecol Sci2018
30086748Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution.BMC Palliat Care2018
28324920An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).Cancer Res Treat2018
27855989Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.Gynecol Oncol2017
28108027A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.Gynecol Oncol2017
28246515Efficacy of Prophylactic Uterine Artery Embolization before Obstetrical Procedures with High Risk for Massive Bleeding.Korean J Radiol2017
28187098Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy.Int J Gynecol Cancer2017
29185544Erratum: Author correction.Obstet Gynecol Sci2017
28538383Stratification of risk groups according to survival after recurrence in endometrial cancer patients.Medicine (Baltimore)2017
27793841Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.Cancer Res2017
27670259Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy.J Gynecol Oncol2017
27670257Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.J Gynecol Oncol2017
27894165Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.J Gynecol Oncol2017
28028994An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016).J Gynecol Oncol2017
25093908Reliability of tumour grade 1 and endometrioid cell type on preoperative endometrial biopsy.J Obstet Gynaecol2015
26176626Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.PLoS One2015
26023670Long (27-nucleotides) small inhibitory RNAs targeting E6 protein eradicate effectively the cervical cancer cells harboring human papilloma virus.Obstet Gynecol Sci2015
25951724Intensive systemic chemotherapy is effective against recurrent malignant Brenner tumor of the ovary: An analysis of 10 cases within a single center.Taiwan J Obstet Gynecol2015
25500455A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.Gynecol Obstet Invest2015
25470688Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution.Int J Gynecol Cancer2015
25325183Association between pelvic organ prolapse and bone mineral density in postmenopausal women.J Obstet Gynaecol2015
24231954Preoperative nomogram for the identification of lymph node metastasis in early cervical cancer.Br J Cancer2014
25408586Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: long-term results at a single institution.J Korean Med Sci2014
24936796Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.PLoS One2014
24694057Urethral diverticulum misdiagnosed with cystocele.J Obstet Gynaecol2014
24397772Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.BJOG2014
  • 1 - 50 of 70

Recommended Authors

Uniformed Services of the Health Sciences Gynecologic Cancer Center of Excellence
Career Start Year 2007
Number of shared co-authors 0
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 0
Eberhard Karls University Tubingen
Career Start Year 2005
Number of shared co-authors 0
Westmead Hospital
Career Start Year 2003
Number of shared co-authors 0
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
University Hospital
Career Start Year 2002
Number of shared co-authors 0
Perlmutter Cancer Center
Career Start Year 1999
Number of shared co-authors 1
Westchester Medical Center
Career Start Year 1998
Number of shared co-authors 1
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 0
University Claude Bernard Lyon I
Career Start Year 1997
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 0
Westmead Hospital
Career Start Year 1995
Number of shared co-authors 0
University of Southern California
Career Start Year 1995
Number of shared co-authors 0
John A. Burns School of Medicine, University of Hawaii
Career Start Year 1995
Number of shared co-authors 1
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 2
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 0
Barts Health NHS Trust
Career Start Year 1993
Number of shared co-authors 1
University of Glasgow
Career Start Year 1992
Number of shared co-authors 2
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 1
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 0
Clinica Quirurgica 2 (Surgical Clinic 2), Hospital Maciel
Career Start Year 1990
Number of shared co-authors 1
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
University of British Columbia
Career Start Year 1987
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 0
Duke School of Medicine
Career Start Year 1983
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 52
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 7
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Co-authored papers 6
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 1
Wonju Severance Christian Hospital
Co-authored papers 1
Co-authored papers 1
Ahngook Pharmaceutical Co.
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 1
Bio-IT Research Center, Hallym University
Co-authored papers 1